Tasnim Lat D.O.

Lat, T. I., M. K. McGraw and H. D. White (2021). “Gender Differences in Critical Illness and Critical Care Research.” Clin Chest Med 42(3): 543-555.

Full text of this article.

Gender is emerging as a factor that may impact the trajectory of critical illness; clinical trials in critical care have largely enrolled men with little attention to equal distribution of sexes. Distribution of admission to the intensive care unit and utilization of resources differs by gender. Sex hormones are thought to impact the course of critical illness. Management and outcomes in sepsis and acute respiratory distress syndrome have been demonstrated to differ by gender as well as in pregnancy. Outcomes of critically ill patients may be impacted by gender.

Lat, T.I., Patel, C.D., Ehrig, J.C., Moslander, C. and Sanchez, J.F. (2020). “Therapeutic Options in the Treatment of SARS-CoV-2 in the Pregnant Patient.” Am J Obstet Gynecol MFM Sep 12;100224. [Epub ahead of print.].

Full text of this article.

The SARS-CoV-2 pandemic has resulted in the development of various therapeutics to treat and prevent major complications related to the virus; pregnant patients are vulnerable to acquiring SARS-CoV-2 due to frequent contact with the healthcare setting. Despite publication of a plethora of case series and randomized control trials of SARS- CoV-2 therapeutics, few have addressed treatment in the pregnant population. To date, there have been no published review of therapeutics in the pregnant patient infected with SARS-CoV-2. We provide the first review of available treatments for SARS-CoV-2, various trials with inclusion and exclusion of the pregnant patients, and potential side effects of each treatment in the pregnant patient.